Identification of Genetic Causes of Bicuspid Aortic Valve Disease

NCT01026571 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 11000

Last updated 2026-04-01

No results posted yet for this study

Summary

BAVgenetics is a partnership between Investigators at Boston University, Brigham and Women's Hospital, and Massachusetts General Hospital dedicated to discovering the genetic causes of bicuspid aortic valve disease and associated aortic disease.

Conditions

  • Bicuspid Aortic Valve

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER
  • Brigham and Women's Hospital

    collaborator OTHER
  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Boston University

    lead OTHER

Principal Investigators

  • Simon C Body, MD MPH · Boston University, Anesthesiology Department

Eligibility

Min Age
14 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026571 on ClinicalTrials.gov